Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Memory loss can point in more than one direction. A patient may seem to fit Alzheimer’s disease, only to have signs that also ...

A blood biomarker for Alzheimer's disease also indicates damage to the heart and kidneys, complicating early and clinical ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

Doctors can diagnose fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), using blood tests that measure serum liver enzyme levels. Elevated enzyme levels ...

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...

Alzheimer’s disease is hard to diagnose. But proteins in the blood might provide clarity. A series of recent findings, presented at the annual Alzheimer’s Association International Conference in ...

Dr. Omar Al-Heeti is an assistant professor of medicine at Southern Illinois University and practices internal medicine with a specialty in infectious diseases. He received his medical degree from the ...

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...